1. Clinical challenges of glioma and pregnancy: a systematic review

   • A. van Westrhenen
   • J. T. Senders
   • M. L. D. Broekman

   Topic Review Open access 06 April 2018 Pages: 1 - 11

   

2. Tumor-related epilepsy: epidemiology, pathogenesis and management

   • Dillon Y. Chen
   • Clark C. Chen
   • Sonya G. Wang

   Topic Review 24 May 2018 Pages: 13 - 21

   

3. Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas

   • Anupam Kumar
   • Subhashree Nayak
   • Chitra Sarkar

   Laboratory Investigation Open access 21 June 2018 Pages: 23 - 31

   

4. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups

   • Karina Bezerra Salomão
   • Gustavo Alencastro Veiga Cruzeiro
   • Luiz Gonzaga Tone

   Laboratory Investigation 26 March 2018 Pages: 33 - 42

   

5. Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis

   • Hidemitsu Nakagawa
   • Yoshihiro Yui
   • Kazuyuki Itoh

   Laboratory Investigation 06 April 2018 Pages: 43 - 50

   

6. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines

   • Mirella Baroni
   • Suely Kazue Nagahashi Marie
   • Carlos Alberto Scrideli

   Laboratory Investigation 18 April 2018 Pages: 51 - 60

   

7. Diagnostic performance of apparent diffusion coefficient parameters for glioma grading

   • Qun Wang
   • JiaShu Zhang
   • BaiNan Xu

   Clinical Study 24 March 2018 Pages: 61 - 68

   

8. Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000–2014

   • Erin C. Peckham-Gregory
   • Roberto E. Montenegro
   • Joshua D. Schiffman

   Clinical Study 16 April 2018 Pages: 69 - 75

9. Neuroimaging classification of progression patterns in glioblastoma: a systematic review

   • Rory J. Piper
   • Keerthi K. Senthil
   • Stephen J. Price

   Clinical Study 30 March 2018 Pages: 77 - 88

10. The expression profile of PD-L1 and CD8⁺ lymphocyte in pituitary adenomas indicating for immunotherapy

    • Peng-fei Wang
    • Ting-jian Wang
    • Chang-Xiang Yan

    Clinical Study 21 April 2018 Pages: 89 - 95

    

11. Glioblastoma (GBM) effects on quantitative MRI of contralateral normal appearing white matter

    • Hatef Mehrabian
    • Wilfred W. Lam
    • Greg J. Stanisz

    Clinical Study 28 March 2018 Pages: 97 - 106

    

12. Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience

    • Niamh Coleman
    • Vasiliki Michalarea
    • Juanita Lopez

    Clinical Study 10 April 2018 Pages: 107 - 116

    

13. Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis

    • A. Dara
    • B. B. Mook
    • J. E. C. Bromberg

    Clinical Study 09 April 2018 Pages: 117 - 123

    

14. Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome

    • Aikaterini Kotrotsou
    • Ahmed Elakkad
    • Rivka R. Colen

    Clinical Study 04 April 2018 Pages: 125 - 133

    

15. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800

    • Sarah E. Miller
    • Willemieke S. Tummers
    • Eben L. Rosenthal

    Clinical Study Open access 06 April 2018 Pages: 135 - 143

    

16. Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM

    • Lindsay S. Rowe
    • John A. Butman
    • Andra V. Krauze

    Clinical Study 16 May 2018 Pages: 145 - 152

    

17. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome

    • Narayan Adhikari
    • Ahitagni Biswas
    • Subhash Chander

    Clinical Study 09 April 2018 Pages: 153 - 166

    

18. Tumor growth dynamics in serially-imaged low-grade glioma patients

    • Chloe Gui
    • Suzanne E. Kosteniuk
    • Joseph F. Megyesi

    Clinical Study 09 April 2018 Pages: 167 - 175

    

19. Acceptance and compliance of TTFields treatment among high grade glioma patients

    • Julia Onken
    • Franziska Staub-Bartelt
    • Martin Misch

    Clinical Study 11 April 2018 Pages: 177 - 184

    

20. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas

    • Bao Wang
    • Peng Zhao
    • Yingchao Liu

    Clinical Study 26 April 2018 Pages: 185 - 193

    

21. The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials

    • Srinivas Raman
    • Fabio Y. Moraes
    • Gustavo N. Marta

    Clinical Study 04 June 2018 Pages: 195 - 203

22. Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer

    • SooYoon Sung
    • Sea-Won Lee
    • Yeon-Sil Kim

    Clinical Study 11 April 2018 Pages: 205 - 213

    

23. Intraoperative linguistic performance during awake brain surgery predicts postoperative linguistic deficits

    • Wei-Han Chang
    • Yu-Cheng Pei
    • Pin-Yuan Chen

    Clinical Study Open access 10 April 2018 Pages: 215 - 223

    

24. Pembrolizumab for primary malignant melanoma of the central nervous system

    • Chakib El Habnouni
    • Claire Bléchet
    • Guido Bens

    Letter to the Editor 02 April 2018 Pages: 225 - 227

    

25. Information needs and requirements in patients with brain tumours

    • Kay Mursch

    Letter to the Editor 10 April 2018 Pages: 229 - 229